Stocks TAC Financial statements
Financial statementsTRANSALTA CORP financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data TRANSALTA CORP files with the SEC in its annual reports.
In CAD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2017 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,397 | 2,307 | 2,249 | 2,347 | 2,101 | 2,721 | 2,976 | 3,355 | 2,845 | 2,405 |
| Cost of revenue | 963 | 1,016 | 1,100 | 1,086 | 968 | |||||
| Gross profit | 1,434 | 1,291 | 1,149 | 1,261 | 1,133 | 1,489 | 1,635 | 2,183 | 1,794 | 1,420 |
| Operating income | 478 | 138 | 160 | 335 | -99 | -239 | 531 | 1,089 | 585 | 140 |
| Pre-tax income | 314 | -54 | -96 | 193 | -303 | -380 | 353 | 880 | 319 | -141 |
| Income tax | 38 | 64 | -6 | 17 | -50 | 45 | 192 | 84 | 80 | 17 |
| Net income to minority interests | 107 | 42 | 108 | 94 | 34 | 112 | 111 | 101 | 10 | -20 |
| Net income | 169 | -160 | -198 | 82 | -287 | -537 | 50 | 695 | 229 | -138 |
| EBITDA | 1,079 | 773 | 734 | 925 | 555 | 290 | 1,130 | 1,710 | 1,116 | 719 |
| EPS, basic | 0.41 | -0.66 | -0.86 | 0.18 | -1.22 | -2.13 | 0.01 | 2.33 | 0.59 | -0.64 |
| EPS, diluted | 0.41 | -0.66 | -0.86 | 0.18 | -1.22 | -2.13 | 0.01 | 2.33 | 0.59 | -0.64 |
Balance sheet
| FY2017 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 305 | 314 | 89 | 411 | 703 | 947 | 1,134 | 348 | 337 | 205 |
| Receivables | 703 | 933 | 756 | 462 | 583 | 651 | 1,589 | 807 | 767 | 699 |
| Inventory | 213 | 219 | 242 | 251 | 238 | 167 | 157 | 157 | 134 | 111 |
| Total current assets | 1,554 | 1,709 | 1,312 | 1,341 | 1,902 | 2,197 | 3,714 | 1,580 | 1,773 | 1,336 |
| Property, plant and equipment | 6,824 | 6,578 | 6,164 | 6,207 | 5,822 | 5,320 | 5,556 | 5,714 | 6,020 | 5,665 |
| Lease right-of-use assets | 52 | 146 | 141 | 95 | 126 | 117 | 120 | 111 | ||
| Goodwill | 464 | 463 | 464 | 464 | 463 | 463 | 464 | 464 | 517 | 516 |
| Intangible assets | 355 | 364 | 373 | 318 | 313 | 256 | 252 | 223 | 281 | 243 |
| Total assets | 10,996 | 10,304 | 9,428 | 9,508 | 9,747 | 9,226 | 10,741 | 8,659 | 9,499 | 8,661 |
| Accounts payable | 413 | 595 | 496 | 413 | 599 | 689 | 1,346 | 809 | 756 | 613 |
| Short-term debt | 623 | 729 | 130 | 494 | 97 | 837 | 170 | 526 | 567 | 170 |
| Total current liabilities | 1,217 | 1,608 | 880 | 1,117 | 935 | 1,931 | 2,888 | 1,742 | 2,569 | 1,830 |
| Total liabilities | 6,333 | 4,944 | 5,872 | 4,756 | 6,051 | 6,633 | 8,752 | 6,995 | 7,656 | 7,196 |
| Total debt | 4,361 | 3,707 | 3,267 | 3,212 | 3,361 | 3,267 | 3,653 | 3,466 | 3,808 | 3,593 |
| Retained earnings | -933 | -1,209 | -1,496 | -1,455 | -1,826 | -2,453 | -2,514 | -2,567 | -2,458 | -2,730 |
| Shareholders' equity | 3,511 | 3,326 | 2,997 | 2,961 | 2,352 | 1,582 | 1,110 | 1,537 | 1,746 | 1,399 |
| Minority interests | 1,152 | 1,059 | 1,137 | 1,101 | 1,084 | 1,011 | 879 | 127 | 97 | 66 |
| Total equity | 4,663 | 4,385 | 4,134 | 4,062 | 3,436 | 2,593 | 1,989 | 1,664 | 1,843 | 1,465 |
| Total liabilities and equity | 10,996 | 10,304 | 9,428 | 9,508 | 9,747 | 9,226 | 10,741 | 8,659 | 9,499 | 8,661 |
Cash flow statement
| FY2017 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 276 | -118 | -90 | 176 | -253 | -425 | 161 | 796 | 239 | -158 |
| Depreciation and amortization | 601 | 635 | 574 | 590 | 654 | 529 | 599 | 621 | 531 | 579 |
| Cash from operations | 744 | 626 | 820 | 849 | 702 | 1,001 | 877 | 1,464 | 796 | 646 |
| Capital expenditures | -358 | -338 | -277 | -417 | -486 | -480 | -918 | -875 | -311 | -249 |
| Cash from investing | -327 | 87 | -394 | -512 | -687 | -472 | -741 | -814 | -520 | -418 |
| Debt repaid | -88 | -814 | -1,179 | -96 | -489 | -92 | -621 | -164 | -131 | -736 |
| Share buybacks | 0 | 0 | -23 | -68 | -57 | -4 | -52 | -87 | -143 | -24 |
| Dividends paid | -52 | -30 | -50 | -30 | -49 | -39 | -46 | -51 | -52 | -52 |
| Cash from financing | -163 | -703 | -651 | -14 | 272 | -282 | 45 | -1,432 | -291 | -362 |
| Exchange rate effect | -3 | -1 | 0 | -1 | 5 | -3 | 6 | -4 | 4 | 2 |
| Net change in cash | 251 | 9 | -225 | 322 | 292 | 244 | 187 | -786 | -11 | -132 |
| Free cash flow | 386 | 288 | 543 | 432 | 216 | 521 | -41 | 589 | 485 | 397 |
| Interest paid | 235 | 230 | 188 | 185 | 201 | 220 | 229 | 277 | 269 | 282 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 59.0% | Gross profit / revenue. |
| Operating margin | 5.8% | Operating income / revenue. |
| EBITDA margin | 29.9% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -5.9% | Pre-tax income / revenue. |
| Net margin | -5.7% | Net income / revenue. |
| FCF margin | 16.5% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 26.9% | Cash from operations / revenue. |
| Return on equity (ROE) | -8.8% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -1.5% | Net income / average total assets. |
| Return on invested capital (ROIC) | 2.2% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| Capex / revenue | 10.4% | Capital expenditures / revenue. |
| D&A / revenue | 24.1% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -15.5% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -6.9% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 2.7% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -20.8% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -4.6% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 4.6% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | -76.1% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | -35.9% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA growth, 1y | -35.6% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -14.0% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 5.3% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | -160.3% | Net income vs the same period a year earlier. Only from a positive base. |
| EPS growth, 1y | -208.5% | EPS vs the same period a year earlier. Only from a positive base. |
| Operating cash flow growth, 1y | -18.8% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -9.7% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | -1.6% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -18.1% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 5y | 12.9% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | -19.9% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 8.0% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | -9.9% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | -8.8% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -6.9% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | -2.3% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 0.73x | Current assets / current liabilities. |
| Quick ratio | 0.49x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.11x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 2.57x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 41.5% | Total debt / total assets. |
| Liabilities / assets | 83.1% | Total liabilities / total assets. |
| Net debt | CA$3.39B | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 4.71x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Working capital | -CA$494.0M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 8.8% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | CA$640.0M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.26x | Revenue / average total assets. |
| Fixed asset turnover | 0.41x | Revenue / average property, plant and equipment. |
| Receivables turnover | 3.28x | Revenue / average receivables. |
| Days sales outstanding | 111 days | 365 x average receivables / revenue. |
| Capex / operating cash flow | 38.5% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -CA$0.64 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | -CA$0.64 | Net income per basic share, as reported (split-adjusted). |
| Dividends / FCF | 13.1% | Dividends paid / free cash flow, when free cash flow is positive. |
| Buybacks / FCF | 6.0% | Share buybacks / free cash flow, when free cash flow is positive. |
What was TRANSALTA CORP's revenue in fiscal 2025?
TRANSALTA CORP reported revenue of CA$2.41B for fiscal 2025, 15.5% lower than the year before.
Was TRANSALTA CORP profitable in fiscal 2025?
No. It reported a net loss of CA$138.0M.
How much free cash flow did TRANSALTA CORP generate in fiscal 2025?
Cash from operations of CA$646.0M minus capital expenditures of CA$249.0M left free cash flow of CA$397.0M.